How to explain the contradiction of microRNA 200c expression and survival in solid tumors?: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3687-3690

  Wang, Hui Yu ^a   Shen, Jie ^b   Jiang, Chun Ping ^b   Liu, Bao Rui ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Meta analysis; MicroRNA 200c expression; Solid tumors; Survival

Indexed keywords

MICRORNA; MIRN200 MICRORNA, HUMAN; TUMOR MARKER;

COLORECTAL TUMOR; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HUMAN; MALE; META ANALYSIS; METABOLISM; MORTALITY; OVARY TUMOR; PANCREAS TUMOR; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR;

COLORECTAL NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901999615     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3687     Document Type: Article

References (34)

1. Berezovskaya O, Schimmer AD, Glinskii AB, et al (2005). Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res, 65, 2378-86.
2. Bonnomet A, Brysse A, Tachsidis A, et al (2010). Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia, 15, 261-73.
3. Chang L, Guo F, Wang Y, et al (2013). MicroRNA-200c Regulates the Sensitivity of Chemotherapy of Gastric Cancer SGC7901/DDP Cells by Directly Targeting RhoE. Pathol Oncol Res, 20, 93-8.
4. Chang YS, Tomaso E, McDonald DM, et al (2000). Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA, 97, 14608-13.
5. Cittelly DM, Dimitrova I, Howe EN, et al (2012). Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol Cancer Ther, 11, 2556-65.
6. Cochrane DR, Spoelstra NS, Howe EN, et al (2009). MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther, 8, 1055-66.
7. Dykxhoorn DM (2010). MicroRNAs and metastasis: little RNAs go a long way. Cancer Res, 70, 6401-6.
8. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
9. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
10. Hurteau GJ, Carlson JA, Spivack SD, et al (2007). Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res, 67, 7972-6.
11. Karaayvaz M, Zhang C, Liang S, et al (2012). Prognostic significance of miR-205 in endometrial cancer. PLoS One, 7, e35158.
12. Kopp F, Oak PS, Wagner E, et al (2012). miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS One, 7, e50469.
13. Kosaka N, Iguchi H, Yoshioka Y, et al (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem, 285, 17442-52.
14. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
15. Ma XL, Xiao ZL, Liu L, et al (2012). Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev, 13, 1137-44.
16. Marchini S, Cavalieri D, Fruscio R, et al (2011). Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol, 12, 273-85.
17. Mocellin S, Hoon D, Ambrosi A, et al (2006). The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res, 12, 4605-13.
18. Mongroo PS, Rustgi AK (2010). The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther, 10, 219-22.
19. Nilsen TW (2007). Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet, 23, 243-9.
20. Parmar MK, Torri V, Stewart L, (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34.
21. Rahbari NN, Aigner M, Thorlund K, et al (2010). Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology, 138, 1714-26.
22. Rana TM (2007). Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol, 8, 23-36.
23. Rokavec M, Wu W, Luo JL, et al (2012). IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell, 45, 777-89.
24. Scheel C, Weinberg RA (2012). Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol, 22, 396-403.
25. Shi L, Zhang S, Wu H, et al (2013). MiR-200c Increases the Radiosensitivity of Non-Small-Cell Lung Cancer Cell Line A549 by Targeting VEGF-VEGFR2 Pathway. PLoS One, 8, e78344.
26. Thomson JM, Newman M, Parker JS, et al (2006). Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev, 20, 2202-7.
27. Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 16.
28. Toiyama Y, Hur K, Tanaka K, et al (2013). Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer. Ann Surg, doi: 10.1097/SLA.0b013e3182a6909d.
29. Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, et al (2012). Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med, 10, 186.
30. Wang FB, Yang XQ, Yang S, et al (2011). A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis. Asian Pac J Cancer Prev, 12, 2629-35.
31. Williamson PR, Smith CT, Hutton JL, et al (2002). Aggregate data meta-analysis with time-to-event outcomes. Stat Med, 21, 3337-51.
32. Xu TP, Zhu CH, Zhang J, et al (2013). MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. Asian Pac J Cancer Prev, 14, 7085-90.
33. Yu J, Ohuchida K, Mizumoto K, et al (2010). MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer, 9, 169.
34. Zhang L, Riethdorf S, Wu G, et al (2012). Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res, 18, 5701-10.